EMBC: American Century Reports 8.9% Stake in Embecta Corp.

Embecta Corp. Schedule 13G disclosure shows passive beneficial ownership positions by American Century entities and Stowers Institute in Embecta common stock.

Rhea-AI Filing Summary

Embecta Corp. Schedule 13G disclosure shows passive beneficial ownership positions by American Century entities and Stowers Institute in Embecta common stock. American Century Investment Management, American Century Companies and Stowers Institute report aggregate beneficial ownership of 5,195,948 shares (8.9% of the class), while American Century Capital Portfolios reports 3,460,379 shares (5.9% of the class). The filing states these securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing also notes that ACIM acts as investment adviser to accounts holding these securities and that no single ACIM client owns more than 5% of the class.

Insights

Financial Analyst

TL;DR: Large passive stakes disclosed — American Century entities hold 8.9% and 5.9% positions in EMBC; holdings declared non‑control and held in ordinary course.

This Schedule 13G reports material passive stakes by American Century-related filers and Stowers Institute. The combined position of 5,195,948 shares (8.9% of the class) is above typical 5% disclosure thresholds and is therefore material to share‑ownership tables and potential voting pools. The certification that holdings are in the ordinary course and not intended to change control limits immediate governance implications, but the disclosure increases transparency around major holders and could affect perceived free float and block trade liquidity.

Impactful: Yes — ownership is material but presented as passive.

Corporate Governance Expert

TL;DR: Material ownership disclosed without intent to influence control; governance risk remains limited absent further filings or coordination.

The filers identify themselves with reporting person types and show sole voting and dispositive power for the reported share totals. Item 10 certifies acquisition and holding in the ordinary course, which differentiates this Schedule 13G disclosure from an active Schedule 13D activist filing. From a governance standpoint, the disclosure requires monitoring but does not on its face signal a change in control strategy or coordinated engagement.

Impactful: Yes — material size, but governance implications appear neutral based on the certification.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares of EMBC does American Century Investment Management and related entities report owning?

The filing shows an aggregate beneficial ownership of 5,195,948 shares (8.9% of the class) reported by American Century Investment Management, American Century Companies and Stowers Institute.

What does American Century Capital Portfolios report owning in EMBC?

American Century Capital Portfolios reports beneficial ownership of 3,460,379 shares (5.9% of the class).

Does the filing indicate these holdings are intended to influence control of Embecta (EMBC)?

No. Item 10 certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of changing or influencing control of the issuer.

Does ACIM hold these shares on behalf of other clients and could a single ACIM client own more than 5%?

ACIM serves as investment adviser to accounts that have rights to dividends or sale proceeds with respect to these securities; the filing states that no single ACIM client owns more than 5% of the class.

What type of SEC disclosure is this for EMBC?

This document is a Schedule 13G disclosure, which is used to report passive beneficial ownership above reporting thresholds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2025 - 09:01 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Embecta Corp.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

29082K105

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 29082K105

1

Names of Reporting Persons

American Century Capital Portfolios, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,460,379.00
6	Shared Voting Power
7	Sole Dispositive Power 3,460,379.00
8	Shared Dispositive Power

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,460,379.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.9 %

12

Type of Reporting Person (See Instructions)

IV

SCHEDULE 13G

CUSIP No. 29082K105

1

Names of Reporting Persons

American Century Investment Management, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,029,197.00
6	Shared Voting Power
7	Sole Dispositive Power 5,195,948.00
8	Shared Dispositive Power

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,195,948.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 29082K105

1

Names of Reporting Persons

American Century Companies, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,029,197.00
6	Shared Voting Power
7	Sole Dispositive Power 5,195,948.00
8	Shared Dispositive Power

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,195,948.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.9 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 29082K105

1

Names of Reporting Persons

Stowers Institute for Medical Research

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,029,197.00
6	Shared Voting Power
7	Sole Dispositive Power 5,195,948.00
8	Shared Dispositive Power

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,195,948.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.9 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Embecta Corp.
(b)	Address of issuer's principal executive offices: 330 Kimball Drive, Suite 300, Parsipanny, NJ, 07054
Item 2.
(a)	Name of person filing: American Century Capital Portfolios, Inc. American Century Investment Management, Inc. American Century Companies, Inc. Stowers Institute for Medical Research
(b)	Address or principal business office or, if none, residence: 4500 Main Street 9th Floor Kansas City, Missouri 64111
(c)	Citizenship: Maryland Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 29082K105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: See the response(s) to Item 11 on the attached cover page(s).
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. ("ACIM") serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. This Item identifies each subsidiary of American Century Companies, Inc. ("ACC"), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are subject of this schedule (the "Subject Securities"). American Century Investment Management, Inc. ("ACIM") is a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940.
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. Not applicable
Item 9.	Notice of Dissolution of Group.
	Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Not applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

American Century Capital Portfolios, Inc.

Signature:	American Century Capital Portfolios, Inc.
Name/Title:	/s/ John Pak / Senior Vice President
Date:	08/14/2025

American Century Investment Management, Inc.

Signature:	American Century Investment Management, Inc.
Name/Title:	/s/ John Pak / Senior Vice President
Date:	08/14/2025

American Century Companies, Inc.

Signature:	American Century Companies, Inc.
Name/Title:	/s/ John Pak / Senior Vice President
Date:	08/14/2025

Stowers Institute for Medical Research

Signature:	Stowers Institute for Medical Research
Name/Title:	/s/ Joselyn Verschelden / Authorized Signer
Date:	08/14/2025

Exhibit Information

EXHIBIT Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule. Dated this 14th day of August, 2025. AMERICAN CENTURY CAPITAL PORTFOLIOS, INC. ("ACCP") AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM") AMERICAN CENTURY COMPANIES, INC. ("ACC") By: __/s/ John Pak_________________ John Pak Senior Vice President, ACCP, ACIM and ACC STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC By: __/s/ Joselyn Verschelden_________________ Joselyn Verschelden Authorized Signer